Evolución de la función pulmonar en la enfermedad intersticial pulmonar asociada a esclerodermia tratada con ciclofosfamida: Análisis retrospectivo de una serie de casos en un hospital universitario

Enghelmayer, Juan Ignacio; Giovini, Vanina; Acuña, Silvana; Legarreta, Cora Gabriela; Altube, Soledad; Craviotto, Federico; Cuenca, Erika.
Rev. am. med. respir ; 14(4): 504-518, dic. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-750544

Documentos relacionados

  1. Treatment-Resistant Depression in Argentina: results from a longitudinal analysis of the TRAL Study
  2. Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease.
  3. Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials.
  4. Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.